Why Is CytomX Therapeutics, Inc. (CTMX) Stock Down Today?

Summary

CytomX Therapeutics, Inc. (CTMX) is trading down -2.00% at $2.94, reflecting a negative shift in investor sentiment today. The stock opened at $3.05 and has moved between $2.89 and $3.05 so far.

Trading volume is 3640603, which is 47% below its average, and the price action suggests selling interest.

Technically, CTMX is trading below its 50-day moving average of $4.13 and below its 200-day moving average of $4.01, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns CTMX a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +65.65% in 1 month ($4.87), +133.58% in 1 year ($6.87), and +533.07% in 5 years ($18.61).

View the full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement.
Stay informed and make better investment decisions.